PMID: 697433Oct 1, 1978Paper

Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer

Annals of Surgery
J H WaneboM K Schwartz

Abstract

The usefulness of the CEA as an indicator of recurrence and a guide to selected second-look surgery was evaluated from a retrospective analysis of 358 patients with colorectal cancer and from a prospective experience with 16 patients all of whom had been admitted for second-look surgery because of postoperative elevations of CEA only. Our previous experience had shown that after curative resection the CEA usually returned to normal levels (less than 5 ng/ml) within one month, but became elevated at time of clinically obvious recurrence being very high in patients with liver metastases, but only moderately elevated or normal in patients with local recurrence. All 16 patients had previously had curative resection of colorectal cancer; 13 in the rectum or rectosigmoid and three in the right colon. There were 13 Dukes' C and three Dukes' B cancers. All had been followed clinically and by CEA testing at three monthly intervals and were considered free of disease (NED) at time of CEA elevation. The median disease free interval was 13 months (range 4-57 months) and the median CEA prompting admission for second-look operation was 21 ng/ml (range 10-56 ng/ml). The sites of recurrence were liver in six, lung in two and localized disease ...Continue Reading

References

May 3, 1976·JAMA : the Journal of the American Medical Association·J C AlexanderP B Chretien
Mar 13, 1978·JAMA : the Journal of the American Medical Association·C G MoertelV L Go
Mar 11, 1975·The Journal of Surgical Research·B A BivinsJ C Parker
Dec 1, 1973·Lancet·D P Stevens, I R Mackay
Apr 17, 1972·JAMA : the Journal of the American Medical Association·G ReynosoG P Murphy
Jul 1, 1973·Journal of Clinical Pathology·S K Khoo, I R Mackay
Sep 1, 1965·The Journal of Experimental Medicine·P Gold, S O Freedman
Feb 1, 1972·American Journal of Surgery·P Lo GerfoH J Hansen
Jul 15, 1971·The New England Journal of Medicine·P Lo GerfoH J Hansen
Jan 1, 1971·The American Journal of Digestive Diseases·T L MooreN Zamcheck

❮ Previous
Next ❯

Citations

May 1, 1991·Seminars in Surgical Oncology·H J WaneboM R Llaneras
May 1, 1991·Seminars in Surgical Oncology·A Sardi
Jan 1, 1983·Cancer Metastasis Reviews·D J Laurence, A M Neville
Jan 1, 1981·The Japanese Journal of Surgery·H Tomoda, M Furusawa
Sep 1, 1987·The Japanese Journal of Surgery·T KogaK Inokuchi
Apr 1, 1982·Diseases of the Colon and Rectum·J J SzymenderaA W Szawowski
Nov 1, 1981·Diseases of the Colon and Rectum·R W BeartA J Schutt
Nov 1, 1981·Diseases of the Colon and Rectum·J WedellH W Schlipköter
May 25, 1988·Journal of Immunological Methods·J G TehI F McKenzie
Jan 1, 1985·Critical Reviews in Oncology/hematology·J E Shively, J D Beatty
Mar 29, 1979·The New England Journal of Medicine·C E Welch, R A Malt
Mar 1, 1980·British Medical Journal·J P CochraneW W Slack
Jan 1, 1979·Postgraduate Medical Journal·H Ellis
Sep 11, 1991·World Journal of Surgery·G Steele
Sep 1, 1985·Cancer Treatment Reviews·S E Bates, D L Longo
Apr 1, 1980·American Journal of Surgery·G SteeleJ Maltz
Jan 1, 1993·Current Problems in Cancer·R Bleday, W D Wong
Nov 1, 1991·Current Problems in Cancer·E L Jacobs, C M Haskell
Aug 1, 1980·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G MarianiM G Toni
May 1, 1980·The Journal of Surgical Research·E W MartinJ P Minton
Oct 1, 1981·The Australian and New Zealand Journal of Surgery·I Gough
Dec 30, 2014·World Journal of Surgical Oncology·Zhipeng Sun, Nengwei Zhang
Jul 1, 1989·The Journal of Surgical Research·Y TabuchiY Saitoh
Jan 1, 1992·Acta Oncologica·G TanumK M Tveit
Dec 15, 2015·The Cochrane Database of Systematic Reviews·Brian D NicholsonDavid Mant
May 1, 1981·Cancer·F F Attiyeh, M W Stearns
Jan 1, 1990·Surgery·K D GriffithA E Chang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.